Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HAPevolve is a for-profit healthcare services and solutions company focused on helping hospitals and health systems address operational, compliance, financial, staffing, and emergency preparedness challenges. It is a wholly owned subsidiary of The Hospital and Healthsystem Association of Pennsylvania and primarily serves healthcare providers through a mix of consulting, training, technology-enabled solutions, and endorsed partner offerings. The company appears to be commercially focused rather than drug-development focused, with offerings spanning emergency operations planning, cybersecurity, revenue-cycle improvement, supply chain optimization, workforce support, and analytics. Its best-known proprietary solution appears to be PREP, a mobile and web-based emergency operations planning platform for healthcare organizations. HAPevolve is healthcare-related, but it is not a biotech or pharmaceutical developer and does not appear to maintain a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HAPevolve.